These results suggest that NF-κB and JNK/SAPK signaling are activated and involved in the progression of inflammation and carcinogenesis in Cx32ΔTg rats in the HFD–DMN NASH model. The gene discussed is MAPK9; the disease is metabolic dysfunction-associated steatohepatitis.